2023
A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States
Liapakis A, Agbim U, Bittermann T, Dew M, Deng Y, Gan G, Emre S, Hunt H, Olthoff K, Locke J, Jesse M, Kumar V, Pillai A, Verna E, Lentine K, Group T. A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation 2023, 37: e14967. PMID: 36938716, DOI: 10.1111/ctr.14967.Peer-Reviewed Original ResearchConceptsDonor liver transplantDonor liver transplantationLiver transplant centersGood first optionLDLT centersLiver transplantLiver transplantationWaitlist candidatesTransplant centersDonor factorsLDLTTransplant providersConsensus conferenceSurgical expertiseElectronic surveyAmerican SocietyImportant barriersFirst optionExclusion rateKey barriersHigh levelsTransplantationTransplantFacilitatorsCenter
2021
Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States
Azar MM, Cohen E, Ma L, Cissé OH, Gan G, Deng Y, Belfield K, Asch W, Grant M, Gleeson S, Koff A, Gaston DC, Topal J, Curran S, Kulkarni S, Kovacs JA, Malinis M. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States. Clinical Infectious Diseases 2021, 74: 639-647. PMID: 34017984, PMCID: PMC9012955, DOI: 10.1093/cid/ciab474.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsCases of PCPPneumocystis pneumoniaClinic visitsRisk factorsClinic exposureLow absolute lymphocyte countRisk of PCPAbsolute lymphocyte countFrequent clinic visitsPneumocystis jirovecii pneumoniaStrong risk factorNon-white raceCase-control analysisBelatacept groupMonthly infusionsTransplant recipientsBaseline characteristicsJirovecii pneumoniaLymphocyte countMultilocus sequence typingInterhuman transmissionRespiratory specimensUnivariate analysisEpidemiologic data